Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.1 (
phosphodiesterase
)
18,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The mechanism of interferon resistance was studied in two clones of Daudi cells,
DIF2
and DIF3, which exhibit respectively moderate and pronounced resistance to both the antiviral and antiproliferative actions of human interferons-alpha and -beta. Clones
DIF2
and DIF3 were found to possess specific high affinity interferon receptors similar to those of parental Daudi cells. However,
DIF2
cells, which have a tetraploid karyotype, had approximately twice as many interferon-binding sites as either DIF3 or parental Daudi cells. One of the first detectable changes in Daudi cells following interferon treatment is a rapid increase in the intracellular concentration of cyclic GMP. No increase in cyclic GMP was observed in
DIF2
or DIF3 cells treated with interferon-alpha. However, neither
DIF2
nor DIF3 cells respond to sodium azide, a nonphysiological inducer of cyclic GMP. Interferon treatment was found to induce the production of 2'-5'-oligo-isoadenylate synthetase in
DIF2
and DIF3 cells in a manner similar to parental Daudi cells, indicating that these cells possess functional interferon receptors. The levels of 2'-5'-oligo-isoadenylate synthetase and 2'-5' A
phosphodiesterase
activity were similar in all three cell lines, suggesting that the interferon resistance of clones
DIF2
and DIF3 was not due to a deficiency of pp(A2' p)nA.
...
PMID:Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance. 631 52
Differentiation-inducing factor 1(DIF-1) and
DIF-2
are signaling molecules that control chemotaxis in Dictyostelium discoideum. Whereas DIF-1 suppresses chemotaxis in shallow cAMP gradients,
DIF-2
enhances chemotaxis under the same conditions via a
phosphodiesterase
, response regulator A (RegA), which is a part of the DhkC-RdeA-RegA two-component signaling system. In this study, to investigate the mechanism of the chemotaxis regulation by
DIF-2
, we examined the effects of
DIF-2
(and DIF-1) on chemotaxis in rdeA(-) and dhkC(-) mutant strains. In the parental wild-type strains, chemotactic cell movement was suppressed with DIF-1 and enhanced with
DIF-2
in shallow cAMP gradients. In contrast, in both rdeA(-) and dhkC(-) strains, chemotaxis was suppressed with DIF-1 but unaffected by
DIF-2
. The results suggest that
DIF-2
modulates chemotaxis via the DhkC-RdeA-RegA signaling system.
...
PMID:Differentiation-inducing factor 2 modulates chemotaxis via the histidine kinase DhkC-dependent pathway in Dictyostelium discoideum. 2691 66